000167190 001__ 167190
000167190 005__ 20240229133533.0
000167190 0247_ $$2doi$$a10.3390/cancers13020357
000167190 0247_ $$2pmid$$apmid:33478065
000167190 0247_ $$2altmetric$$aaltmetric:98839947
000167190 037__ $$aDKFZ-2021-00181
000167190 041__ $$aeng
000167190 082__ $$a610
000167190 1001_ $$0P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aJansen, Lina$$b0$$eFirst author
000167190 245__ $$aEstimation of the Potentially Avoidable Excess Deaths Associated with Socioeconomic Inequalities in Cancer Survival in Germany.
000167190 260__ $$aBasel$$bMDPI$$c2021
000167190 3367_ $$2DRIVER$$aarticle
000167190 3367_ $$2DataCite$$aOutput Types/Journal article
000167190 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1611583765_14751
000167190 3367_ $$2BibTeX$$aARTICLE
000167190 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000167190 3367_ $$00$$2EndNote$$aJournal Article
000167190 500__ $$a#EA:C070#LA:C070#
000167190 520__ $$aMany countries have reported survival inequalities due to regional socioeconomic deprivation. To quantify the potential gain from eliminating cancer survival disadvantages associated with area-based deprivation in Germany, we calculated the number of avoidable excess deaths. We used population-based cancer registry data from 11 of 16 German federal states. Patients aged ≥15 years diagnosed with an invasive malignant tumor between 2008 and 2017 were included. Area-based socioeconomic deprivation was assessed using the quintiles of the German Index of Multiple Deprivation (GIMD) 2010 on a municipality level nationwide. Five-year age-standardized relative survival for 25 most common cancer sites and for total cancer were calculated using period analysis. Incidence and number of avoidable excess deaths in Germany in 2013-2016 were estimated. Summed over the 25 cancer sites, 4100 annual excess deaths (3.0% of all excess deaths) could have been avoided each year in Germany during the period 2013-2016 if relative survival were in all regions comparable with the least deprived regions. Colorectal, oral and pharynx, prostate, and bladder cancer contributed the largest numbers of avoidable excess deaths. Our results provide a good basis to estimate the potential of intervention programs for reducing socioeconomic inequalities in cancer burden in Germany.
000167190 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000167190 588__ $$aDataset connected to CrossRef, PubMed,
000167190 650_7 $$2Other$$aGermany
000167190 650_7 $$2Other$$aavoidable deaths
000167190 650_7 $$2Other$$acancer
000167190 650_7 $$2Other$$asocioeconomic deprivation
000167190 650_7 $$2Other$$asurvival
000167190 7001_ $$aKanbach, Josephine$$b1
000167190 7001_ $$0P:(DE-He78)a79a61dd9934f6115f9383fd1dc21d76$$aFinke, Isabelle$$b2
000167190 7001_ $$0P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aArndt, Volker$$b3
000167190 7001_ $$aEmrich, Katharina$$b4
000167190 7001_ $$aHolleczek, Bernd$$b5
000167190 7001_ $$aKajüter, Hiltraud$$b6
000167190 7001_ $$aKieschke, Joachim$$b7
000167190 7001_ $$aMaier, Werner$$b8
000167190 7001_ $$aPritzkuleit, Ron$$b9
000167190 7001_ $$aSirri, Eunice$$b10
000167190 7001_ $$aSchwettmann, Lars$$b11
000167190 7001_ $$aErb, Cynthia$$b12
000167190 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b13$$eLast author
000167190 7001_ $$aGroup, For The German Cancer Survival Working$$b14
000167190 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers13020357$$gVol. 13, no. 2, p. 357 -$$n2$$p357$$tCancers$$v13$$x2072-6694$$y2021
000167190 909CO $$ooai:inrepo02.dkfz.de:167190$$pVDB
000167190 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000167190 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a79a61dd9934f6115f9383fd1dc21d76$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000167190 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000167190 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000167190 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000167190 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000167190 9141_ $$y2021
000167190 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2018$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2020-09-11
000167190 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2018$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-09-11
000167190 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-09-11
000167190 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000167190 9201_ $$0I:(DE-He78)M110-20160331$$kM110$$lM110 Epidemiologisches Krebsregister Baden-Württemberg$$x1
000167190 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x2
000167190 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x3
000167190 980__ $$ajournal
000167190 980__ $$aVDB
000167190 980__ $$aI:(DE-He78)C070-20160331
000167190 980__ $$aI:(DE-He78)M110-20160331
000167190 980__ $$aI:(DE-He78)C120-20160331
000167190 980__ $$aI:(DE-He78)HD01-20160331
000167190 980__ $$aUNRESTRICTED